Every material is a story about scale. The property a customer actually buys, whether that is strength, flexibility, dispersion, conductivity or a controlled release profile, is decided by structure at a level nobody can see: the arrangement of atoms in a lattice, the entanglement of polymer chains, the roughness of a nanoparticle’s surface, the way fibrils knit into a network. Materials companies are therefore in an unusual position.
They sell performance, but the reason for that performance is invisible, static under the microscope and impossible to film while it happens. Scientific animation exists to close that gap: it shows a material doing the thing that makes it valuable, at the scale where it happens.
This is increasingly a life sciences story too. Nanoparticles that protect and deliver mRNA, silica carriers for vaccines, resorbable polymers for implants, hydrogels for wound care, nanocellulose in cosmetics and coatings: materials science is where a growing share of biotech and healthcare innovation now begins.
This article walks through how 3D animation is used across the field, from the physics of structure to the formats materials companies commission most often, using our own projects as reference.
Are you interested in modular content and omnichannel materials?
Materials, visualised
Materials scientists think in a chain of cause and effect: processing determines structure, structure determines properties, and properties determine how a material performs in the real world. Animation follows that chain naturally, because each link lives at a different scale and a 3D camera can move between them in a single shot.
At the atomic level, bonds and crystal lattices decide whether a solid is a ductile metal, a brittle ceramic or a flexible polymer.
At the nanoscale, features such as particle size, surface area, porosity and surface chemistry govern how a material interacts with everything around it, which is why a nanoparticle can carry a drug, catalyse a reaction or scatter light in ways its bulk form never could.
At the microscale, grains, phases, fibres and networks set mechanical behaviour: how a composite resists a crack, how a gel holds water, how a dispersion stays stable. And at the macroscale, all of this becomes a product a customer can hold, apply, implant or swallow.
What makes materials such a strong subject for animation is that the interesting behaviour is dynamic. Self-assembly, dispersion, degradation, controlled release, crack propagation, self-healing and phase change all unfold over time and below the limit of vision. A micrograph shows a snapshot; an animation shows the mechanism.
Get this free Guide with
5 key steps for The Digital Transformation
of Scientific Communication
Types of scientific animation in materials science
The formats we describe in our overview of the types of medical animation all have a materials science version. What changes is the science inside them.
– Technology and platform animation
This is the flagship format for materials companies, ingredient suppliers and deep-tech spin-outs.
A platform animation explains what the material is, how it is made and why its structure gives it properties competitors cannot match, in a video short enough for a website hero, a congress screen or an investor meeting.
Because a platform is licensed or sold into many applications, the same animation usually needs to work for chemists, formulators, business developers and non-specialist decision makers at once, so the storyline has to be built from the science outwards rather than from a product claim.
– Nanomaterial and drug delivery mechanism animation
In pharma and biotech, the mechanism of action increasingly belongs to a material rather than a molecule.
Lipid nanoparticles encapsulating mRNA, silica or polymer carriers protecting nucleic acids from degradation, micelles that release a payload in the acidic environment of a tumour or an endosome, and inhalable particles that cross the alveolar wall are all delivery stories in which the carrier’s structure, surface and stability are the science.
MoA animation shows the particle forming, loading, travelling, crossing a barrier and releasing, which is exactly the sequence a scientific audience and a regulatory reviewer both need to follow.

– Biomaterials and medical device animation
Implants, bone scaffolds, dental materials, surgical meshes, coatings, sutures and wound dressings are materials science made clinical.
Here the animation has to show a material interacting with living tissue over time: a resorbable polymer degrading as bone grows into its place, a coating preventing bacterial adhesion, a hydrogel maintaining a moist wound environment.
The 3D camera can compress months of integration into seconds and reveal what is happening at the interface between material and cell, something no clinical image can show.
– Process and manufacturing animation
Sometimes the differentiator is not the material but how it is produced.
Fibrillation, dispersion, extrusion, sintering, coating and additive manufacturing can all be animated at plant scale and at molecular scale within the same video, so an audience understands both what the process does and why it produces a better structure.
This format is particularly useful for B2B sales, technical training and partner onboarding, where a diagram of a production line and a schematic of the resulting microstructure are usually shown separately and rarely connected.
– Product and branding animation
Speciality chemicals, cosmetic actives, excipients, packaging materials and advanced textiles all have a marketing problem: the ingredient is the hero, but it is invisible in the finished product.
Branding animation makes the material visible, often by mixing real footage of the product with 3D elements that reveal what is happening inside it. A cream, a paint, a tablet or a fabric becomes a window into the technology that makes it work.
– Educational and investor animation
Universities, research institutes and early-stage companies use animation to explain a new material to audiences who will never read the paper.
The same core assets can be scripted twice, once for a scientific viewer who wants the mechanism and once for an investor who wants the opportunity, a dual approach we have used directly with nanotechnology clients.
Increasingly, these assets are also delivered as interactive 3D viewers or AR and VR experiences, so a structure can be rotated, sectioned and explored rather than watched.

Materials science at 3DforScience
Our materials work sits at the meeting point of chemistry, physics and biology, which is where our in-house scientific team is most at home.
For Sappi Biotech, we produced an animation of Valida, a high-quality nanocellulose in which micro and nanofibrillated cellulose suspended in water forms a three-dimensional network that accommodates particles homogeneously, a property that opens applications from paints, coatings and adhesives to cosmetics and concrete. The video explains the technology at a glance on the company’s website and is reused in presentations.
For Thalia Therapeutics (formerly known as N4 Pharma), we turned the client’s illustrations into a 3D animation of Nuvec, a silica nanoparticle whose irregular surface structure traps and protects nucleic acids such as mRNA and pDNA on their way to the cell, with the script adapted for two distinct audiences: scientific viewers and potential investors.
Across all of these projects the method is the same. Our scientists build the storyline from the structure up, checking every scale, every interaction and every claim before our designers and animators begin, so that the finished video holds up in front of a materials chemist and still makes sense to a purchaser or an investor.
Assets are designed to be reused across web, congress, sales decks, social media and interactive formats, and we work directly with R&D, marketing and business development teams rather than through third parties.
If your advantage lives at the nanoscale, we can show your audience exactly what it looks like and why it matters.